Ocular manifestations of Fabry disease within in a single kindred

Anderson, 1898, A case of “angiokeratoma.”, Br J Dermatol, 10, 113, 10.1111/j.1365-2133.1898.tb16317.x Fabry, 1898, A contribution to the understanding of modular hemorrhagic purpura, Arch Dermatol Syphilis, 43, 187, 10.1007/BF01986897 Staretz-Chacham, 2009, Lysosomal storage disorders in the newborn, Pediatrics, 123, 1191, 10.1542/peds.2008-0635 Desnick, 2001, alpha-Galactosidase A deficiency: Fabry disease Spada, 2006, High incidence of later-onset Fabry disease revealed by newborn screening, Am J Hum Genet, 79, 31, 10.1086/504601 Laney, 2008, Diagnosis of Fabry disease via analysis of family history, J Genet Couns, 17, 79, 10.1007/s10897-007-9128-x Brady, 1967, Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency, N Engl J Med, 276, 1163, 10.1056/NEJM196705252762101 Deegan, 2006, Natural history of Fabry disease in females in the Fabry Outcome Survey, J Med Genet, 43, 347, 10.1136/jmg.2005.036327 Gupta, 2005, The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease: a cross-sectional study of a large cohort of clinically affected heterozygous women, Medicine, 84, 261, 10.1097/01.md.0000178976.62537.6b Wilcox, 2008, Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry, Mol Genet Metab, 93, 112, 10.1016/j.ymgme.2007.09.013 Wang, 2007, Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life, Genet Med, 9, 34, 10.1097/GIM.0b013e31802d8321 Zarate, 2008, Fabry's disease, Lancet, 372, 1427, 10.1016/S0140-6736(08)61589-5 Bloomfield, 1978, Eye findings in the diagnosis of Fabry's disease. Patients with renal failure, JAMA, 240, 647, 10.1001/jama.1978.03290070049015 Franceschetti, 1976, Fabry disease: ocular manifestations, Birth Defects Orig Artic Ser, 12, 195 Hauser, 2004, Results of an ophthalmologic screening programme for identification of cases with Anderson-Fabry disease, Ophthalmologica, 218, 207, 10.1159/000076846 Libert, 1982, Tortuosities of retinal and conjunctival vessels in lysosomal storage diseases, Birth Defects Orig Artic Ser, 18, 347 Mastropasqua, 2006, Corneal and conjunctival manifestations in Fabry disease: in vivo confocal microscopy study, Am J Ophthalmol, 141, 709, 10.1016/j.ajo.2005.11.053 Nguyen, 2005, Ophthalmological manifestations of Fabry disease: a survey of patients at the Royal Melbourne Fabry Disease Treatment Centre, Clin Experiment Ophthalmol, 33, 164, 10.1111/j.1442-9071.2005.00990.x Orssaud, 2003, Ocular manifestations in Fabry disease: a survey of 32 hemizygous male patients, Ophthalmic Genet, 24, 129, 10.1076/opge.24.3.129.15609 Samiy, 2008, Ocular features of Fabry disease: diagnosis of a treatable life-threatening disorder, Surv Ophthalmol, 53, 416, 10.1016/j.survophthal.2008.04.005 Sher, 1979, The ocular manifestations in Fabry's disease, Arch Ophthalmol, 97, 671, 10.1001/archopht.1979.01020010327008 Sodi, 2007, Ocular manifestations of Fabry's disease: data from the Fabry Outcome Survey, Br J Ophthalmol, 91, 210, 10.1136/bjo.2006.100602 Spaeth, 1965, Fabry's disease. Its ocular manifestations, Arch Ophthalmol, 74, 760, 10.1001/archopht.1965.00970040762005 Peters, 2001, Anderson-Fabry's disease: alpha-galactosidase deficiency, Lancet, 357, 138, 10.1016/S0140-6736(00)03554-6 Dovie, 2006, Acute onset of halos and glare: bilateral corneal epithelial edema with cystic eruptions—atypical presentation of amiodarone keratopathy, Optometry, 77, 76, 10.1016/j.optm.2005.12.002 Falke, 2009, The microstructure of cornea verticillata in Fabry disease and amiodarone-induced keratopathy: a confocal laser-scanning microscopy study, Graefes Arch Clin Exp Ophthalmol, 247, 523, 10.1007/s00417-008-0962-9 Mehta, 2004, Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey, Eur J Clin Invest, 34, 236, 10.1111/j.1365-2362.2004.01309.x Eng, 2007, Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry, J Inherit Metab Dis, 30, 184, 10.1007/s10545-007-0521-2 Eng, 2001, Safety and efficacy of recombinant human alpha-galactosidase A–replacement therapy in Fabry's disease, N Engl J Med, 345, 9, 10.1056/NEJM200107053450102 Copt, 1999, Corneal thickness in ocular hypertension, primary open-angle glaucoma, and normal tension glaucoma, Arch Ophthalmol, 117, 14, 10.1001/archopht.117.1.14 La Rosa, 2001, Central corneal thickness of Caucasians and African Americans in glaucomatous and nonglaucomatous populations, Arch Ophthalmology, 119, 23 Morrone, 2003, Fabry disease: molecular studies in Italian patients and X inactivation analysis in manifesting carriers, J Med Genet, 40, 103, 10.1136/jmg.40.8.e103 Hughes, 2005, Vascular complications of Fabry disease: enzyme replacement and other therapies, Acta Paediatr Suppl, 94, 28, 10.1080/08035320510028760 Abe, 1992, Ischemic optic neuropathy in a female carrier with Fabry's disease, Ophthalmologica, 205, 83, 10.1159/000310318 Sher, 1978, Central retinal artery occlusion complicating Fabry's disease, Arch Ophthalmol, 96, 815, 10.1001/archopht.1978.03910050421003 Utsumi, 1997, High incidence of thrombosis in Fabry's disease, Intern Med, 36, 327, 10.2169/internalmedicine.36.327 MacDermot, 2001, Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females, J Med Genet, 38, 769, 10.1136/jmg.38.11.769 Whybra, 2001, Clinical manifestation in female Fabry disease patients, Contrib Nephrol, 245, 10.1159/000060196 Olivova, 2009, Effect of sample collection on alpha-galactosidase A enzyme activity measurements in dried blood spots on filter paper, Clin Chim Acta, 159, 10.1016/j.cca.2009.02.008 Desnick, 1973, Fabry disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine and leukocytes, J Lab Clin Med, 81, 157 Shabbeer, 2002, Fabry disease: 45 novel mutations in the alpha-galactosidase A gene causing the classical phenotype, Mol Genet Metab, 76, 23, 10.1016/S1096-7192(02)00012-4